Activated STAT3 can be either pro-oncogenic or tumor-suppressive according to the tumor etiology and mutational landscape (101), and it considers as a critical transcription factor for Th17 differentiation, while represses the development of Tregs (102). The gene discussed is STAT3; the disease is neoplasm.